Exane Derivatives’s Alibaba BABA Stock Holding History

Exane Derivatives’s Portfolio BABA Stock Details BABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-261	Closed	-$27K	–	831
2020 Q3	$27K	Hold	261	–	–	0.01%	409
2020 Q2	$214K	Sell	261 -100	-28%	-$20.8K	0.06%	209
2020 Q1	$418K	Buy	+361	New	+$75.3K	0.12%	135
2015 Q3	–	Sell	-300	Closed	-$25.2K	–	539
2015 Q2	$25.2K	Hold	300	–	–	﹤0.01%	330
2015 Q1	$97.6K	Buy	+300	New	+$27.1K	0.01%	267

Other funds holding BABA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Exane Derivatives's BABA Position: Q2 2022 in Review

Exane Derivatives reduced its Alibaba (BABA) stake by 10% in Q2 2022, selling an estimated $106K and leaving 9,429 shares worth $1.07M. The position accounts for 0.62% of the portfolio, ranked #37.

Exane Derivatives first reported a position in BABA in Q4 2014 and has held it in 24 quarters since. The position peaked at $5.18M in Q1 2020. 1,303 funds tracked by Wall St. Rank hold BABA as of Q2 2022.

Exane Derivatives held 9,429 shares of Alibaba worth $1.07M as of Q2 2022.
Exane Derivatives sold 1,082 Alibaba shares in Q2 2022, an estimated $106K.
Alibaba made up 0.62% of Exane Derivatives's portfolio in Q2 2022, its #37 holding.
Exane Derivatives first reported a position in Alibaba in Q4 2014 and has held it in 24 quarters since.
Exane Derivatives's Alibaba position peaked at $5.18M in Q1 2020.
1,303 funds tracked by Wall St. Rank held Alibaba as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.